Imaflex Valuation

IFX Stock  CAD 1.25  0.01  0.79%   
Today, the firm appears to be overvalued. Imaflex retains a regular Real Value of C$1.1 per share. The prevalent price of the firm is C$1.25. Our model calculates the value of Imaflex from evaluating the firm fundamentals such as Return On Equity of 0.0749, current valuation of 71.94 M, and Return On Asset of 0.051 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Imaflex's valuation include:
Price Book
1.0357
Enterprise Value
71.9 M
Enterprise Value Ebitda
5.5757
Price Sales
0.6048
Forward PE
7.3529
Overvalued
Today
1.25
Please note that Imaflex's price fluctuation is dangerous at this time. Calculation of the real value of Imaflex is based on 3 months time horizon. Increasing Imaflex's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Imaflex stock is determined by what a typical buyer is willing to pay for full or partial control of Imaflex. Since Imaflex is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Imaflex Stock. However, Imaflex's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.25 Real  1.1 Hype  1.25 Naive  1.27
The intrinsic value of Imaflex's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Imaflex's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
1.10
Real Value
4.28
Upside
Estimating the potential upside or downside of Imaflex helps investors to forecast how Imaflex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Imaflex more accurately as focusing exclusively on Imaflex's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.000.000.00
Details
Hype
Prediction
LowEstimatedHigh
0.061.254.43
Details
Naive
Forecast
LowNext ValueHigh
0.031.274.45
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Imaflex's intrinsic value based on its ongoing forecasts of Imaflex's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Imaflex's closest peers.

Imaflex Cash

1.49 Million

Imaflex Valuation Trend

Analysing the historical paterns of Imaflex's enterprise value and its market capitalization is a good way to estimate and gauge the value of Imaflex over time and is usually enough for investors to make rational market timing decisions.

Imaflex Total Value Analysis

Imaflex is currently estimated to have takeover price of 71.94 M with market capitalization of 76.05 M, debt of 11.41 M, and cash on hands of 328 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Imaflex fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
71.94 M
76.05 M
11.41 M
328 K

Imaflex Investor Information

About 45.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.04. Some equities with similar Price to Book (P/B) outperform the market in the long run. Imaflex last dividend was issued on the 18th of May 2005. Based on the key measurements obtained from Imaflex's financial statements, Imaflex is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Profit Margin0.05120.0365
Significantly Up
Slightly volatile
Operating Income3.1 M3.4 M
Moderately Down
Slightly volatile

Imaflex Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Imaflex has an asset utilization ratio of 112.12 percent. This indicates that the Company is making C$1.12 for each dollar of assets. An increasing asset utilization means that Imaflex is more efficient with each dollar of assets it utilizes for everyday operations.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Imaflex Ownership Allocation

Imaflex has a total of 52.09 Million outstanding shares. Imaflex secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Imaflex Profitability Analysis

The company reported the revenue of 93.59 M. Net Income was 508.78 K with profit before overhead, payroll, taxes, and interest of 18.05 M.

About Imaflex Valuation

Our relative valuation model uses a comparative analysis of Imaflex. We calculate exposure to Imaflex's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Imaflex's related companies.
Last ReportedProjected for Next Year
Gross Profit12.4 M8.9 M
Pretax Profit Margin 0.01  0.01 
Operating Profit Margin 0.04  0.05 
Gross Profit Margin 0.14  0.17 

Imaflex Quarterly Retained Earnings

46.68 Million

Additional Tools for Imaflex Stock Analysis

When running Imaflex's price analysis, check to measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.